MAWCM
BIO icon

Mine & Arao Wealth Creation & Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Mine & Arao Wealth Creation & Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-12
Closed -$5.05K – 329
2022
Q4 		$5.05K Hold
12
– – ﹤0.01% 261
2022
Q3 		$5K Hold
12
– – ﹤0.01% 267
2022
Q2 		$6K Hold
12
– – ﹤0.01% 253
2022
Q1 		$7K Hold
12
– – ﹤0.01% 252
2021
Q4 		$9K Buy
+12
New +$8.98K 0.01% 235

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mine & Arao Wealth Creation & Management's BIO Position: Q1 2023 in Review

Mine & Arao Wealth Creation & Management sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2023, closing a stake of 12 shares — an estimated $5.05K sold.

Mine & Arao Wealth Creation & Management first reported a position in BIO in Q4 2021 and held it in 5 quarters. The position peaked at $9K in Q4 2021. 504 funds tracked by Wall St. Rank hold BIO as of Q1 2023.

  • Mine & Arao Wealth Creation & Management reported no remaining Bio-Rad Laboratories Class A position as of Q1 2023 after selling out during the quarter.
  • Mine & Arao Wealth Creation & Management sold 12 Bio-Rad Laboratories Class A shares in Q1 2023, an estimated $5.05K.
  • Mine & Arao Wealth Creation & Management first reported a position in Bio-Rad Laboratories Class A in Q4 2021 and held it in 5 quarters.
  • Mine & Arao Wealth Creation & Management's Bio-Rad Laboratories Class A position peaked at $9K in Q4 2021.
  • 504 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2023.

Based on Mine & Arao Wealth Creation & Management's 13F filing for Q1 2023, filed 10 May 2023.